Label: FEXOFENADINE HYDROCHLORIDE tablet

  • NDC Code(s): 71309-091-01
  • Packager: Safrel Pharmaceuticals, LLC.
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated March 28, 2023

If you are a consumer or patient please visit this version.

  • ACTIVE INGREDIENT(S)

    Fexofenadine HCl USP 60 mg (for 60 mg)

    Fexofenadine HCl USP 180 mg (for 180 mg)

  • PURPOSE

    Antihistamine

  • USE(S)

    temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:


    • runny nose
    • itchy, water eyes
    • sneezing
    • itching of the nose or throat
  • WARNINGS

    Do not use
    if you have ever had an allergic reaction to this product or any of its ingredients.

    Ask a doctor before use if you have
    kidney disease. Your doctor should determine if you need a different dose.

    When using this product


    • do not take more than directed
    • do not take at the same time as aluminum or magnesium antacids
    • do not take with fruit juices (see Directions)

    Stop use and ask a doctor if
    an allergic reaction to this product occurs. Seek medical help right away.

    If pregnant or breast-feeding
    ask a health professional before use.

  • Keep out of reach of children 

    In case of overdose, get medical help or contact a Poison Control Center right away.

  • DIRECTIONS

    adults and children 12 years of age and over take one 60 mg tablet with water every 12 hours; do not take more than 2 tablets in 24 hours (for 60 mg)
    take one 180 mg tablet with water once a day; do not take more than 1 tablet in 24 hours (for 180 mg) 
     children under 12 years of age do not use
     adults 65 years of age and older ask a doctor
     consumers with kidney disease ask a doctor
  • OTHER INFORMATION

    • Safety-sealed: do not use if foil printed with granules logo under bottle cap is opened or torn.
    • Do not use if carton is opened or if individual blister units are torn or opened.
    • store between 20º and 25ºC (68º and 77ºF)
    • protect from excessive moisture
  • INACTIVE INGREDIENTS

    anhydrous lactose, colloidal silicon dioxide, corn starch, croscarmellose sodium, hypromellose, lactose monohydrate, polyethylene glycol, pregelatinized starch (maize), red iron oxide, stearic acid, titanium dioxide and yellow iron oxide

  • QUESTIONS OR COMMENTS

    Contact 1-844-384-3723 Mon-Fri 8:00 AM EST to 5:00 PM PST



    Distributed By:

    Safrel Pharmaceuticals, LLC
    Bridgewater, NJ 08807

  • PRINCIPAL DISPLAY PANEL

    NDC 71309-091-01 - 100 Count

    Fexo

  • INGREDIENTS AND APPEARANCE
    FEXOFENADINE HYDROCHLORIDE 
    fexofenadine hydrochloride tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:71309-091
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    FEXOFENADINE HYDROCHLORIDE (UNII: 2S068B75ZU) (FEXOFENADINE - UNII:E6582LOH6V) FEXOFENADINE HYDROCHLORIDE180 mg
    Inactive Ingredients
    Ingredient NameStrength
    CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
    FERRIC OXIDE RED (UNII: 1K09F3G675)  
    FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  
    HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)  
    ANHYDROUS LACTOSE (UNII: 3SY5LH9PMK)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    STARCH, CORN (UNII: O8232NY3SJ)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  
    Product Characteristics
    Colororange (PEACH) Scoreno score
    ShapeOVAL (Capsule-shaped) Size17mm
    FlavorImprint Code G6
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:71309-091-01100 in 1 BOTTLE; Type 0: Not a Combination Product01/31/2021
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA21107501/03/2021
    Labeler - Safrel Pharmaceuticals, LLC. (080566287)